Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 6/20 | 0.56 |
| ▸ | CES1 | P23141 | 6/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | PARP1 | P09874 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | AKT1 | P31749 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | F2 | P00734 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7542937 | 0.79 | TDP1 (0.50) | CES2CES1TSHRCYP3A4MAPT | |
| SCHEMBL4133635 | 0.79 | — | — | |
| SCHEMBL7542933 | 0.79 | TDP1 (0.50) | CES2CES1TSHRCYP3A4MAPT | |
| SCHEMBL6046218 | 0.77 | TDP1 (0.56) | CES2CES1TSHRCYP3A4MAPT | |
| SCHEMBL717977 | 0.77 | TDP1 (0.56) | CES2CES1TSHRCYP3A4MAPT | |
| SCHEMBL6401253 | 0.77 | TDP1 (0.56) | CES2CES1TSHRCYP3A4MAPT | |
| SCHEMBL424294 | 0.76 | — | — | |
| SCHEMBL688558 | 0.76 | — | — | |
| Benzil SCHEMBL28225310 | 0.73 | CES2 (0.88) | CES2CES1TSHRCYP3A4MAPT | |
| Benzil SCHEMBL8382614 | 0.73 | CES2 (0.88) | CES2CES1TSHRCYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357488-A1 | CURABLE RESIN COMPOSITION | CANON KK (JP) | 2023-11-09 | — | — | US | claimed |
| US-20190177469-A1 | CURABLE RESIN COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2019-06-13 | — | — | US | claimed |
| US-11827796-B2 | Curable resin composition for three-dimensional shaping and method of manufacturing three-dimensionally shaped product | CANON KABUSHIKI KAISHA (JP) | 2023-11-28 | — | — | US | disclosed |
| US-20230357488-A1 | CURABLE RESIN COMPOSITION | CANON KK (JP) | 2023-11-09 | — | — | US | disclosed |
| CN-112352017-B | Aqueous resin composition and method for producing same | DIC株式会社 | 2023-04-07 | — | — | CN | disclosed |
| WO-2021024894-A1 | AQUEOUS RESIN COMPOSITION AND METHOD FOR PRODUCING SAME | DIC株式会社 | 2021-02-11 | — | — | WO | disclosed |
| CN-112352017-A | Aqueous resin composition and method for producing same | DIC株式会社 | 2021-02-09 | — | — | CN | disclosed |
| US-20190315981-A1 | CURABLE RESIN COMPOSITION FOR THREE-DIMENSIONAL SHAPING AND METHOD OF MANUFACTURING THREE-DIMENSIONALLY SHAPED PRODUCT | CANON KABUSHIKI KAISHA (JP) | 2019-10-17 | — | — | US | disclosed |
| US-20190177469-A1 | CURABLE RESIN COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2019-06-13 | — | — | US | disclosed |
| US-20150025262-A1 | BIS(ARYL)ACETAL COMPOUNDS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2015-01-22 | — | — | US | disclosed |
| US-8933239-B1 | Bis(aryl)acetal compounds | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-13 | — | — | US | disclosed |
| US-20120059119-A1 | THERMOSETTING POLYIMIDE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2012-03-08 | — | — | US | disclosed |
| US-7092608-B2 | Polyimide optical materials, polyimide precursor solutions and optical waveguide elements | KABUSHIKI KAISHA TOSHIBA (JP) | 2006-08-15 | — | — | US | disclosed |
| US-7082244-B2 | Polyimide optical materials, polyimide precursor solutions and optical waveguide elements | KABUSHIKI KAISHA TOSHIBA (JP) | 2006-07-25 | — | — | US | disclosed |
| US-20060159413-A1 | POLYIMIDE OPTICAL MATERIALS, POLYIMIDE PRECURSOR SOLUTIONS AND OPTICAL WAVEGUIDE ELEMENTS | KABUSHIKI KAISHA TOSHIBA (JP) | 2006-07-20 | — | — | US | disclosed |
| US-20040197064-A1 | Polyimide optical materials, polyimide precursor solutions and optical waveguide elements | KABUSHIKI KAISHA TOSHIBA (JP) | 2004-10-07 | — | — | US | disclosed |
| EP-1173438-A1 | SUBSTITUTED IMIDAZOLES, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 2002-01-23 | — | — | EP | disclosed |
| US-6255532-B1 | REACTING PYRILIUM SALTS WITH PHOSPHINE; CONSTANT PRESSURE; ACID CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-03 | — | — | US | disclosed |
| US-6252117-B1 | NONCATALYTIC REACTION OF PYRILLIUM SALT WITH PHOSPHINE SUPPLIED DURING THE REACTION TO MAINTAIN A UNIFORM PHOSPHINE PARTIAL PRESSURE | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-26 | — | — | US | disclosed |
| WO-2000063208-A1 | SUBSTITUTED IMIDAZOLES, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 2000-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150025262-A1 | BIS(ARYL)ACETAL COMPOUNDS | BOLA2; BOLA2B, TARS1, CBR1 | CES2 1281/4885CES1 1604/4885TSHR 679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.